Exane Derivatives’s Procter & Gamble PG Stock Holding History

Exane Derivatives’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$533K	Sell	3,705 -145	-4%	-$21.8K	0.31%	78
2022 Q1	$588K	Sell	3,850 -440	-10%	-$68.8K	0.17%	167
2021 Q4	$702K	Sell	4,290 -500	-10%	-$74.2K	0.17%	137
2021 Q3	$670K	Sell	4,790 -572	-11%	-$81.1K	0.16%	136
2021 Q2	$734K	Sell	5,362 -656	-11%	-$88.8K	0.17%	121
2021 Q1	$815K	Sell	6,018 -2,356	-28%	-$307K	0.23%	94
2020 Q4	$1.17M	Buy	8,374 +1,351	+19%	+$189K	0.34%	65
2020 Q3	$976K	Buy	7,023 +1,562	+29%	+$207K	0.28%	87
2020 Q2	$653K	Buy	5,461 +1,334	+32%	+$156K	0.17%	109
2020 Q1	$454K	Sell	4,127 -5,315	-56%	-$638K	0.13%	132
2019 Q4	$1.19M	Buy	9,442 +7,380	+358%	+$903K	0.22%	100
2019 Q3	$256K	Sell	2,062 -5,684	-73%	-$672K	0.05%	212
2019 Q2	$849K	Sell	7,746 -918	-11%	-$97.8K	0.15%	113
2019 Q1	$901K	Sell	8,664 -46,083	-84%	-$4.49M	0.18%	125
2018 Q4	$5.03M	Buy	54,747 +42,092	+333%	+$3.76M	0.9%	18
2018 Q3	$1.05M	Buy	+12,655	New	+$1.03M	0.2%	107
2016 Q4	–	Sell	-8,597	Closed	-$772K	–	673
2016 Q3	$772K	Sell	8,597 -5,251	-38%	-$456K	0.12%	116
2016 Q2	$1.17M	Buy	13,848 +4,447	+47%	+$365K	0.19%	80
2016 Q1	$774K	Buy	9,401 +270	+3%	+$21.8K	0.1%	106
2015 Q4	$725K	Sell	9,131 -3,242	-26%	-$248K	0.1%	97
2015 Q3	$890K	Buy	12,373 +1,400	+13%	+$105K	0.11%	96
2015 Q2	$858K	Buy	10,973 +49	+0.4%	+$3.94K	0.09%	102
2015 Q1	$895K	Buy	10,924 +2,951	+37%	+$254K	0.1%	103
2014 Q4	$726K	Buy	+7,973	New	+$701K	0.1%	118

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's PG Position: Q2 2022 in Review

Exane Derivatives reduced its Procter & Gamble (PG) stake by 3.8% in Q2 2022, selling an estimated $21.8K and leaving 3,705 shares worth $533K. The position accounts for 0.31% of the portfolio, ranked #78.

Exane Derivatives first reported a position in PG in Q4 2014 and has held it in 24 quarters since. The position peaked at $5.03M in Q4 2018. 3,255 funds tracked by Wall St. Rank hold PG as of Q2 2022.

Exane Derivatives held 3,705 shares of Procter & Gamble worth $533K as of Q2 2022.
Exane Derivatives sold 145 Procter & Gamble shares in Q2 2022, an estimated $21.8K.
Procter & Gamble made up 0.31% of Exane Derivatives's portfolio in Q2 2022, its #78 holding.
Exane Derivatives first reported a position in Procter & Gamble in Q4 2014 and has held it in 24 quarters since.
Exane Derivatives's Procter & Gamble position peaked at $5.03M in Q4 2018.
3,255 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.